The median OS was 51.9 months (95% CI, 22.5 to 81.3 months) vs. 14.5 months (95% CI, 9.7 to 19.3 months), and the median DFS was 29.2 months (95% CI, 0 to 59.7 months) vs. 12.0 months (95% CI, 7.0 to 17.0 months) for patients with MGMT-U tumor vs. MGMT-M tumor, respectively. The gene discussed is MGMT; the disease is neoplasm.